International – Mylan recalls 15 lots of blood-pressure drug containing valsartan

Mylan (NASDAQ:MYL) starts a voluntary U.S. recall of select lots of Valsartan-containing products due to trace amounts of an impurity that’s classified as a probable human carcinogen.

Valsartan is used to treat high blood pressure for treating heart failure. It’s also used in combination with amlodipine or hydrochlorothiazide to treat high blood pressure…